| abstract |
The present invention relates to a pharmaceutical composition comprising a polyribonucleotide (RNA) and a cationic agent and formulated as a solid preparation for administration to the gastrointestinal tract. Furthermore, the present invention relates to a method for systemic delivery of RNA to a subject comprising the use of said pharmaceutical composition for systemic delivery of RNA and the step of administering said pharmaceutical composition to the gastrointestinal tract. Furthermore, the present invention relates to a kit. |